The effect of ketamine on mitochondrial bioenergetics, viability, and function: A systematic review
Journal of Psychopharmacology · 07.09.2026
DOI: 10.1177/02698811261481085 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Psychopharmacology, online erschienen am 07.09.2026. Verfasst von Sabrina Wong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Cognition Discovery Foundation, Toronto, ON, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Extant literature indicates mitochondrial dysfunction may contribute to the pathophysiology of depressive disorders. Preclinical data indicate that anesthetic doses of ketamine are associated with deficits in mitochondrial viability and function. Ketamine and esketamine have demonstrated rapid antidepressant effects in persons with difficult-to-treat depressive disorders. Herein, we aim to synthesize literature reporting on the effect of antidepressant doses of ketamine and esketamine in vivo versus in vitro on mitochondrial viability and function.
Methods
We performed a systematic review of previous studies on PubMed, Ovid, and Scopus databases from inception to November 30, 2025. Preclinical studies reporting on the effect of antidepressant doses of ketamine and/or esketamine in mitochondrial viability, structure/morphology, bioenergetics, and metabolic function were sought for inclusion.
Results
Thirteen studies were included. Lower ketamine/esketamine concentrations generally did not adversely affect membrane potential, oxidative phosphorylation, respiration, or bioenergetics, whereas higher concentrations or prolonged exposure induced mitochondrial dysfunction in some models. Additional evaluation of the safety of ketamine/esketamine on mitochondria in humans is required.
Conclusion
Preliminary research suggests that ketamine at lower concentrations may not adversely affect brain mitochondrial viability or bioenergetic function, but requires further validation. The reported effects on mitochondrial viability and function are preclinical, model- and dose-dependent and derived from limited heterogeneous literature. This study generates the hypothesis that ketamine’s antidepressant mechanism of action may be partially mediated by insulin-sensitive metabolic pathways, energetically supporting synaptic remodeling and neurogenesis. Incorporation of mitochondrial and metabolic biomarkers into ketamine clinical trials is a current research imperative.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Brain and Cognition Discovery Foundation, Toronto, ON, Canada.
- Poul Hansen Family Centre for Depression, University Health Network, Toronto, ON, Canada.
- Department of Pharmacology & Toxicology, University of Toronto, ON, Canada.
- Institute of Medical Science, University of Toronto, ON, Canada.
- Department of Psychiatry, University of Thessaly, Larissa, Greece.
- Department of Psychiatry, University of Toronto, ON, Canada.
ORCID-Profile: Sabrina Wong, Stavroula Bargiota, Shreya Vasudeva, Gabrielle Lovell, Joshua D Rosenblat, Roger S McIntyre
Zitieren
APA
Wong, S., Le, G. H., Selby, S., Bargiota, S., Orsini, D. K., Di Luch, S., Vasudeva, S., Lovell, G., Rosenblat, J. D., & McIntyre, R. S. (2026). The effect of ketamine on mitochondrial bioenergetics, viability, and function: A systematic review. Journal of Psychopharmacology. https://doi.org/10.1177/02698811261481085
Vancouver
Wong S, Le GH, Selby S, Bargiota S, Orsini DK, Di Luch S, et al. The effect of ketamine on mitochondrial bioenergetics, viability, and function: A systematic review. Journal of Psychopharmacology. 2026. doi:10.1177/02698811261481085
BibTeX
@article{Wong2026,
author = {Wong, Sabrina and Le, Gia Han and Selby, Simryn and Bargiota, Stavroula and Orsini, Diana K and Di Luch, Sara and Vasudeva, Shreya and Lovell, Gabrielle and Rosenblat, Joshua D and McIntyre, Roger S},
title = {The effect of ketamine on mitochondrial bioenergetics, viability, and function: A systematic review},
journal = {Journal of Psychopharmacology},
year = {2026},
doi = {10.1177/02698811261481085}
}
EUVIMED